Marek Sanak Selected Research

Virus Diseases (Viral Diseases)

1/2022	Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19.
3/2006	The broken balance in aspirin hypersensitivity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marek Sanak Research Topics

Disease

58	Asthma (Bronchial Asthma) 09/2023 - 01/2003
26	Hypersensitivity (Allergy) 03/2023 - 04/2004
20	Inflammation (Inflammations) 06/2023 - 04/2013
13	Aspirin-Induced Asthma 10/2022 - 05/2003
10	COVID-19 06/2023 - 01/2020
9	Eosinophilia 11/2023 - 01/2011
8	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2022 - 03/2009
8	Urticaria (Hives) 01/2019 - 04/2004
7	Macular Degeneration (Age-Related Maculopathy) 05/2022 - 02/2012
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 12/2005
6	Infections 01/2023 - 08/2014
6	Rhinosinusitis 01/2019 - 03/2006
5	Angioedema 01/2019 - 04/2004
4	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022 - 06/2017
4	Coronary Disease (Coronary Heart Disease) 11/2020 - 03/2010
4	Myocardial Infarction 11/2020 - 01/2016
3	Neoplasms (Cancer) 12/2023 - 01/2018
3	Choroidal Neovascularization 03/2021 - 02/2012
3	Metaplasia 01/2021 - 10/2013
3	Hemorrhage 11/2019 - 09/2010
3	Nasal Polyps (Nasal Polyp) 01/2019 - 01/2016
3	Anaphylaxis (Anaphylactic Shock) 01/2019 - 05/2013
3	Atherosclerosis 01/2018 - 03/2010
3	Hearing Loss (Hearing Impairment) 10/2015 - 04/2000
3	Lung Diseases (Lung Disease) 01/2012 - 01/2004
2	Systemic Scleroderma (Systemic Sclerosis) 12/2023 - 08/2023
2	Virus Diseases (Viral Diseases) 01/2022 - 03/2006
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022 - 05/2013
2	Central Serous Chorioretinopathy 10/2021 - 03/2021
2	Necrosis 03/2021 - 01/2018
2	Hypertension (High Blood Pressure) 03/2021 - 02/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2005
2	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 01/2011
2	Thrombosis (Thrombus) 11/2020 - 02/2014
2	Disease Progression 01/2017 - 01/2009

Drug/Important Bio-Agent (IBA)

31	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2023 - 05/2003
18	EicosanoidsIBA 01/2022 - 01/2004
17	Biomarkers (Surrogate Marker)IBA 12/2023 - 04/2013
11	ProstaglandinsIBA 01/2021 - 05/2003
10	MicroRNAs (MicroRNA)IBA 06/2023 - 10/2015
10	LeukotrienesIBA 01/2022 - 10/2010
10	Dinoprostone (PGE2)FDA Link 01/2021 - 05/2003
9	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2022 - 04/2004
8	CytokinesIBA 12/2023 - 01/2012
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2023 - 02/2012
8	Prostaglandin D2IBA 03/2023 - 04/2013
8	Immunoglobulin E (IgE)IBA 01/2022 - 11/2006
7	AntibodiesIBA 01/2022 - 02/2012
6	Antiviral Agents (Antivirals)IBA 06/2023 - 09/2012
6	LipidsIBA 01/2023 - 01/2013
6	Leukotriene E4IBA 01/2021 - 01/2012
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2013
6	SteroidsIBA 01/2020 - 03/2006
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2014 - 03/2006
4	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2023 - 10/2014
4	Interleukin-8 (Interleukin 8)IBA 08/2023 - 01/2019
4	InterferonsIBA 01/2023 - 09/2012
4	Arachidonic Acid (Vitamin F)IBA 01/2019 - 03/2006
4	Retinaldehyde (Retinal)IBA 01/2016 - 02/2012
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2006 - 05/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2023 - 01/2012
3	Complement System Proteins (Complement)IBA 05/2022 - 01/2015
3	Interleukin-4 (Interleukin 4)IBA 03/2021 - 10/2012
3	ThromboxanesIBA 01/2021 - 01/2016
3	AcidsIBA 01/2021 - 10/2010
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 10/2016
3	ChemokinesIBA 01/2019 - 01/2011
3	Messenger RNA (mRNA)IBA 01/2018 - 08/2014
3	Bevacizumab (Avastin)FDA Link 11/2016 - 02/2012
2	Interleukin-17 (Interleukin 17)IBA 12/2023 - 11/2019
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2023 - 08/2014
2	InflammasomesIBA 06/2023 - 01/2023
2	Antiphospholipid AntibodiesIBA 01/2023 - 02/2014
2	Anticardiolipin AntibodiesIBA 01/2023 - 02/2014
2	factor V LeidenIBA 01/2023 - 11/2020
2	AllergensIBA 01/2023 - 01/2017
2	Prothrombin (Factor II)IBA 01/2023 - 01/2007
2	Thrombin FDA Link 01/2023 - 01/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2022 - 01/2005
2	InterleukinsIBA 03/2021 - 09/2012
2	Interleukin-5 (Interleukin 5)IBA 03/2021 - 10/2012
2	Interleukin-6 (Interleukin 6)IBA 03/2021 - 11/2019
2	Interleukin-10 (Interleukin 10)IBA 03/2021 - 10/2012
2	IsoprostanesIBA 01/2021 - 09/2015
2	Particulate MatterIBA 01/2021 - 07/2014
2	5-oxo-eicosatetraenoic acidIBA 01/2021 - 01/2020
2	11-dehydro-thromboxane B2IBA 01/2021 - 01/2016
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2020 - 01/2019
2	Cocaine (Cocaine HCl)IBA 07/2020 - 01/2019
2	Leukotriene B4IBA 01/2020 - 01/2019
2	Interleukin-13IBA 11/2019 - 10/2013
2	Leukotriene C4IBA 01/2019 - 04/2013
2	ProteomeIBA 01/2019 - 01/2018
2	RNA (Ribonucleic Acid)IBA 11/2018 - 01/2003
2	EnzymesIBA 01/2018 - 01/2004
2	Peptide Hydrolases (Proteases)FDA Link 01/2017 - 01/2005
2	Immunoglobulin G (IgG)IBA 12/2016 - 02/2014

Therapy/Procedure

12	Therapeutics 05/2022 - 01/2012
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018 - 09/2010
2	Secondary Prevention 01/2018 - 01/2007